Alqahtani S - Search Results

1

Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality.

Vell MS, Loomba R, Krishnan A, Wangensteen KJ, Trebicka J, Creasy KT, Trautwein C, Scorletti E, Seeling KS, Hehl L, Rendel MD, Zandvakili I, Li T, Chen J, Vujkovic M, Alqahtani S, Rader DJ, Schneider KM, Schneider CV. Vell MS, et al. Among authors: alqahtani s. JAMA Netw Open. 2023 Jun 1;6(6):e2320222. doi: 10.1001/jamanetworkopen.2023.20222. JAMA Netw Open. 2023. PMID: 37358849 Free PMC article.

2

Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma.

Alqahtani SA, Sanai FM, Alolayan A, Abaalkhail F, Alsuhaibani H, Hassanain M, Alhazzani W, Alsuhaibani A, Algarni A, Forner A, Finn RS, Al-Hamoudi WK. Alqahtani SA, et al. Saudi J Gastroenterol. 2020 Oct;26(Suppl 1):S1-S40. doi: 10.4103/sjg.SJG_477_20. Saudi J Gastroenterol. 2020. PMID: 33078723 Free PMC article. No abstract available.

3

A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations.

Krishnan A, Hamilton JP, Alqahtani SA, A Woreta T. Krishnan A, et al. Intern Emerg Med. 2021 Jun;16(4):815-830. doi: 10.1007/s11739-020-02616-5. Epub 2021 Jan 16. Intern Emerg Med. 2021. PMID: 33453010 Free PMC article. Review.

4

COVID-19: An overview and a clinical update.

Krishnan A, Hamilton JP, Alqahtani SA, Woreta TA. Krishnan A, et al. World J Clin Cases. 2021 Jan 6;9(1):8-23. doi: 10.12998/wjcc.v9.i1.8. World J Clin Cases. 2021. PMID: 33511168 Free PMC article. Review.

5

Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes Mellitus.

Labenz C, Kostev K, Alqahtani SA, Galle PR, Schattenberg JM. Labenz C, et al. Exp Clin Endocrinol Diabetes. 2022 Mar;130(3):172-177. doi: 10.1055/a-1378-4679. Epub 2021 Feb 18. Exp Clin Endocrinol Diabetes. 2022. PMID: 33601426

6

The Impact of NASH to Liver Transplantations With Hepatocellular Carcinoma in the United States.

Younossi ZM, Harring M, Younossi Y, Ong JP, Alqahtani SA, Stepanova M. Younossi ZM, et al. Clin Gastroenterol Hepatol. 2022 Dec;20(12):2915-2917.e1. doi: 10.1016/j.cgh.2021.10.018. Epub 2021 Oct 16. Clin Gastroenterol Hepatol. 2022. PMID: 34666156

7

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma.

Alqahtani SA, Colombo M. Alqahtani SA, et al. Cells. 2021 Nov 9;10(11):3091. doi: 10.3390/cells10113091. Cells. 2021. PMID: 34831314 Free PMC article. Review.

8

Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.

Yuan L, Hanlon CL, Terrault N, Alqahtani S, Tamim H, Lai M, Saberi B. Yuan L, et al. Among authors: alqahtani s. Am J Gastroenterol. 2022 Mar 1;117(3):433-444. doi: 10.14309/ajg.0000000000001591. Am J Gastroenterol. 2022. PMID: 35083985

9

Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.

Krishnan A, Prichett L, Tao X, Alqahtani SA, Hamilton JP, Mezey E, Strauss AT, Kim A, Potter JJ, Chen PH, Woreta TA. Krishnan A, et al. World J Gastroenterol. 2022 Feb 7;28(5):570-587. doi: 10.3748/wjg.v28.i5.570. World J Gastroenterol. 2022. PMID: 35316959 Free PMC article.

10

Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United States.

Muhammad H, Gurakar M, Ting PS, Alsughayer AM, Luu H, Zaffar D, Alqahtani S, Bonder A, Gurakar A, Saberi B. Muhammad H, et al. Among authors: alqahtani s. Exp Clin Transplant. 2022 Mar;20(3):279-284. doi: 10.6002/ect.2021.0479. Exp Clin Transplant. 2022. PMID: 35352634 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,037 results

Search Page